202 related articles for article (PubMed ID: 38397798)
1. Redox Biomarkers and Matrix Remodeling Molecules in Ovarian Cancer.
Supruniuk E; Baczewska M; Żebrowska E; Maciejczyk M; Lauko KK; Dajnowicz-Brzezik P; Milewska P; Knapp P; Zalewska A; Chabowski A
Antioxidants (Basel); 2024 Feb; 13(2):. PubMed ID: 38397798
[TBL] [Abstract][Full Text] [Related]
2. Could circulating biomarkers of nitrosative stress and protein glycoxidation be useful in patients with gastric cancer?
Dorf J; Pryczynicz A; Matowicka-Karna J; Zaręba K; Żukowski P; Zalewska A; Maciejczyk M
Front Oncol; 2023; 13():1213802. PubMed ID: 37503318
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
Pylväs-Eerola M; Karihtala P; Puistola U
BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
[TBL] [Abstract][Full Text] [Related]
4. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
[TBL] [Abstract][Full Text] [Related]
5. VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.
Wakahashi S; Sudo T; Oka N; Ueno S; Yamaguchi S; Fujiwara K; Ohbayashi C; Nishimura R
Transl Res; 2013 Sep; 162(3):181-90. PubMed ID: 23856093
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells.
Xu L; Wu T; Lu S; Hao X; Qin J; Wang J; Zhang X; Liu Q; Kong B; Gong Y; Liu Z; Shao C
Redox Biol; 2020 Sep; 36():101604. PubMed ID: 32554304
[TBL] [Abstract][Full Text] [Related]
7. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
[No Abstract] [Full Text] [Related]
8. Reactive Oxygen Species and Serous Epithelial Ovarian Adenocarcinoma.
Cohen S; Mehrabi S; Yao X; Millingen S; Aikhionbare FO
Cancer Res J (N Y N Y); 2016 Nov; 4(6):106-114. PubMed ID: 28503633
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
10. New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer-A Systematic Review.
Bachmann C
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001616
[TBL] [Abstract][Full Text] [Related]
11. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
[TBL] [Abstract][Full Text] [Related]
12. Validation of a two-tier grading system in an unselected, consecutive cohort of serous ovarian cancer patients.
Battista MJ; Cotarelo C; Almstedt K; Heimes AS; Makris GM; Weyer V; Schmidt M
Arch Gynecol Obstet; 2016 Sep; 294(3):599-606. PubMed ID: 26993518
[TBL] [Abstract][Full Text] [Related]
13. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
14. Expression of DNA Methyltransferase 3B Isoforms Is Associated with DNA Satellite 2 Hypomethylation and Clinical Prognosis in Advanced High-Grade Serous Ovarian Carcinoma.
Del Castillo Falconi VM; Díaz-Chávez J; Torres-Arciga K; Luna-Maldonado F; Gudiño-Gomez AA; Pedroza-Torres A; Castro-Hernández C; Cantú de León D; Herrera LA
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361550
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma.
Sato M; Sato S; Shintani D; Hanaoka M; Ogasawara A; Miwa M; Yabuno A; Kurosaki A; Yoshida H; Fujiwara K; Hasegawa K
BMC Cancer; 2022 Jan; 22(1):59. PubMed ID: 35027024
[TBL] [Abstract][Full Text] [Related]
16. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
17. Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer.
Antoneeva II; Dolgova DR; Gening TP; Abakumova TV; Gening SO; Pirmamedova SS; Fomina AV; Mikheenko AA
Anticancer Agents Med Chem; 2015; 15(9):1141-7. PubMed ID: 26007666
[TBL] [Abstract][Full Text] [Related]
18. Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment.
Escalona RM; Kannourakis G; Findlay JK; Ahmed N
Front Oncol; 2021; 11():796588. PubMed ID: 35047406
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.
Berkel C; Cacan E
Hum Cell; 2021 May; 34(3):862-877. PubMed ID: 33576947
[TBL] [Abstract][Full Text] [Related]
20. Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
Aman M; Ohishi Y; Imamura H; Shinozaki T; Yasutake N; Kato K; Oda Y
Hum Pathol; 2017 Jun; 64():156-163. PubMed ID: 28438620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
